London’s High Court invalidated one of Moderna’s COVID-19 vaccine technology patents, upheld another infringed by Pfizer and BioNTech’s Comirnaty vaccine. Global legal battles continue as companies plan to appeal, ensuring vaccine production remains unaffected.
